✦ LIBER ✦

Anaplastic lymphoma kinase 1 detected by immunohistochemistry in non–small cell lung cancer: a promising feature?—reply

✍ Scribed by Eunhee S. Yi; Jennifer M. Boland; Marie-Christine Aubry; Yang Ping

Book ID: 116534816
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 59 KB
Volume: 41
Category: Article
ISSN: 1532-8392
DOI: 10.1016/j.humpath.2009.11.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anaplastic lymphoma kinase 1 detected by

Anaplastic lymphoma kinase 1 detected by immunohistochemistry in non–small cell lung cancer: a promising feature?

✍ William Sterlacci; Federico Cappuzzo; Spasenija Savic; Lukas Bubendorf; Alexanda 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Vasohibin-1 expression detected by immun

Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer

✍ Zhang, Tao; Yu, Ting-Ting; Zhang, Dong-Ming; Hou, Xiao-Ming; Liu, Xiao-Jun; Zhao 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 705 KB

Detection of Anaplastic Lymphoma Kinase

Detection of Anaplastic Lymphoma Kinase (ALK) Gene Rearrangement in Non-Small Cell Lung Cancer and Related Issues in ALK Inhibitor Therapy

✍ Yi, Eunhee S.; Chung, Jin-Haeng; Kulig, Kimary; Kerr, Keith M. 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 150 KB

Crizotinib: A Review of Its Use in the T

Crizotinib: A Review of Its Use in the Treatment of Anaplastic Lymphoma Kinase-Positive, Advanced Non-Small Cell Lung Cancer

✍ Frampton, James E. 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 517 KB

Crizotinib: a guide to its use in previo

Crizotinib: a guide to its use in previously treated advanced anaplastic lymphoma kinase-positive non-small cell lung cancer in the EU

✍ Hines, Mary; Lyseng-Williamson, Katherine A.; Curran, Monique P. 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 229 KB

369 Timing of responses to crizotinib (P

369 Timing of responses to crizotinib (PF-02341066) in anaplastic lymphoma kinase (ALK)-positive patients with advanced non-small cell lung cancer (NSCLC)

✍ B. Solomon; Y.J. Bang; D.R. Camidge; A.J. Iafrate; E.L. Kwak; R.G. Maki; S.I. Ou 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB